Orthogonal validation of the role of IFNR cluster loss in promoting tolerance to CIN was further provided through a functional genomic approach leveraging genome-wide CRISPR screens in 16q− and 16qeuploid isogenic lines. The gene discussed is IFNAR2; the disease is cervical squamous intraepithelial neoplasia.